Selenium Supplementation Guidelines

Introduction to Selenium Measurement

Plasma selenium levels below 0.75 μmol/L in patients without inflammation indicate a need for supplementation, according to the Clinical Nutrition guidelines 1
Blood selenium measurement, ideally accompanied by CRP and albumin measurements, is the primary method for assessing selenium status, with values <0.4 μmol/L indicating definite deficiency and values <0.75 μmol/L in patients without inflammation triggering supplementation 1

Inflammatory markers such as CRP levels affect selenium status interpretation, with reductions in plasma selenium of 15-25% for CRP 10-40 mg/L, ~35% for CRP 41-80 mg/L, and ~50% for CRP >80 mg/L 1
Correction factors for plasma selenium based on CRP levels:
CRP Level Reduction in Plasma Selenium
10-40 mg/L 15-25%
41-80 mg/L ~35%
>80 mg/L ~50% [1]

CRP Level	Reduction in Plasma Selenium
10-40 mg/L	15-25%
41-80 mg/L	~35%
>80 mg/L	~50% [1]

Excessive selenium supplementation should be avoided due to potential associations with type 2 diabetes and high-grade prostate cancer, with upper limits for plasma selenium before toxicity ranging from 6-12 μmol/L 1
The upper limit for plasma selenium before toxicity is 6-12 μmol/L, with adverse events rare at recommended doses but excessive supplementation to be avoided due to associations with type 2 diabetes and high-grade prostate cancer 1

Concurrent inflammation requires adjusted interpretation of selenium levels, and plasma selenium levels should be monitored, particularly in long-term supplementation 2
Monitoring and correcting inflammatory status is crucial, as inflammation reduces plasma selenium 1
Anti-TPO antibodies should be measured every 3 months to assess response to selenium supplementation, and selenium levels should be rechecked after 7-10 days in cases of severe deficiency, with supplementation continuing for at least 6-12 months if beneficial effects are observed 1

Effective doses of selenium range from 50-200 μg/day, with higher doses (up to 200 μg/day) considered for patients with documented selenium deficiency, higher inflammatory markers, or more severe autoimmune activity, as suggested by Clinical Nutrition guidelines 1
Patients on parenteral nutrition require 60-100 μg/day of selenium, and maintenance therapy may be considered with lower doses (100 μg/day) after normalization of levels 1
Patients with Hashimoto's thyroiditis and selenium levels <0.75 μmol/L in the absence of inflammation should receive selenium supplementation, as recommended by Clinical Nutrition guidelines 1
Certain populations, such as burns patients, trauma patients, and those on renal replacement therapy, may have higher selenium requirements, and patients likely to receive parenteral nutrition for >2 weeks should be tested for selenium deficiency 1
Discontinuation of selenium supplementation may lead to rebound increases in antibody levels, highlighting the need for ongoing monitoring and maintenance therapy, as supported by the American College of Endocrinology 3

Selenium absorption is most efficient through organic forms, particularly selenomethionine, which utilizes amino acid transporters for enhanced cellular uptake compared to inorganic forms, as supported by Clinical Nutrition guidelines 1
Selenomethionine has a bioavailability of 56-81% and utilizes amino acid transport systems to cross cell membranes, allowing for non-specific incorporation into proteins in place of methionine 1

Whole blood selenium, plasma glutathione peroxidase (GPX-3) activity, red cell glutathione peroxidase (GPX-1), and selenoprotein P levels can be used to assess selenium status, with plasma glutathione peroxidase (GPX-3) measurement having a Grade A recommendation for combined testing with blood selenium 1
Urine selenium and hair selenium analysis are less commonly used due to limitations in clinical value 1
A plasma selenium level of ≥1.20 μmol/L is recommended for GPX-3 saturation, with an optimal range of 1.5-1.9 μmol/L for reduced mortality, as stated by Clinical Nutrition guidelines 1